IndraLab
Statements
sparser
"On the contrary, compared to wild-type and the KRKR mutant, the KQKQ mutant exhibited increased interaction with HAUSP in both the nucleus and the cytoplasm, suggesting that nuclear translocation of MDM2 is not required for HAUSP interaction with MDM2, at least in this experimental setting ( xref )."
sparser
"The proteasome has both ubiquitin ligases and DUBs that associate with it (Crosas et al., 2006) , and several DUB-ligase pairs interact directly, including BRCC36-BRCA1, BAP1-BRCA1, USP4-Ro52, USP7-MDM2, USP8-GRAIL, USP20-pVHL, USP33-pVHL and USP44-APC (Kee and Huibregtse, 2007; Marfany and Denuc, 2008; Ventii and Wilkinson, 2008) ."
reach
"Some DUBs have additional binding sites with affinity for the target protein that is ubiquitylated (Ventii and Wilkinson, 2008) ; for example, USP7 binds to a peptide sequence present in its substrates p53, MDM2 (murine double minute 2, an oncoprotein) and the Epstein Barr nuclear antigen-1 (Hu et al., 2006) ."
reach
"On the contrary, compared to wild-type and the KRKR mutant, the KQKQ mutant exhibited increased interaction with HAUSP in both the nucleus and the cytoplasm, suggesting that nuclear translocation of MDM2 is not required for HAUSP interaction with MDM2, at least in this experimental setting (XREF_SUPPLEMENTARY)."
reach
"For example, a previous review from Pfoh et al. (2015) (190) proposed the development of a drug that would block interaction between MDM2 and USP7 in patients with cancer caused by hyperactivation of MDM2, thereby targeting MDM2 for degradation and stabilizing p53.By studying the DUBs and the pathways that are affected by their redox regulation, the upstream and downstream effectors that are deregulated due to DUB inactivity can be identified, and those can also become targets of therapeutic development."
reach
"For example, by interacting with ubiquitin specific protease USP7 (as discussed below), it has been suggested that EBNA1 could interfere with p53 's or MDM2 's own binding to USP7, leading in particular to lower levels of the p53 transcriptional activator, thereby promoting cell survival in response to cellular stress [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR]."